Reading Time: 3 minutesThe use of generative (gen) AI in clinical trials has the potential to decrease the generally lengthy timelines and high costs (Boston Consulting Group, 2023). While it’s been a challenge to gain a full understanding of the implications and capabilities of gen AI—especially in the healthcare and life sciences industry—one promising area is in protocol […]
Article




